ReutersReversing abortion drug's approval would harm public interest, U.S. FDA saysJan 17, 2023By Brendan PiersonMore
The HillFDA argues public harm if court reverses abortion pill approvalJan 18, 2023By Nathaniel WeixelMore
Full CoverageFull Coverage